NCA
EXEL icon

New Century Advisors’s Exelixis EXEL Stock Holding History

New Century Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6K Buy
+403
New +$7.79K 0.01% 99

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New Century Advisors's EXEL Position: Q3 2022 in Review

New Century Advisors opened a new position in Exelixis (EXEL) in Q3 2022: 403 shares worth $6K. The stake represents 0.01% of the portfolio and ranks #99 among its holdings.

400 funds tracked by Wall St. Rank hold EXEL as of Q3 2022.

  • New Century Advisors held 403 shares of Exelixis worth $6K as of Q3 2022.
  • Exelixis was a new New Century Advisors position in Q3 2022.
  • Exelixis made up 0.01% of New Century Advisors's portfolio in Q3 2022, its #99 holding.
  • 400 funds tracked by Wall St. Rank held Exelixis as of Q3 2022.

Based on New Century Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.